A recent meta‐analysis linked increased plasma resistin levels to a higher incidence of obesity‐related cancers, including breast, endometrial, and colorectal cancer; however, resistin levels should not be considered predictive factors.446. The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.